ARS Pharmaceuticals (SPRY) Earnings Date & Reports

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SPRY is expected to report earnings to fall 18.00% to -50 cents per share on August 12

ARS Pharmaceuticals SPRY Stock Earnings Reports

Q2'26

Est.

$-0.50

Q1'26

Missed

by $0.12

Q4'25

Beat

by $0.01

Q3'25

Missed

by $0.06

Q2'25

Est.

$-0.46

The last earnings report on May 15 showed earnings per share of -61 cents, missing the estimate of -49 cents. With 796.14K shares outstanding, the current market capitalization sits at 769.10M.

View a ticker or compare two or three

Compare

SPRY

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for SPRY